Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy.

Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy. Am Heart J. 2005 Mar; 149(3):566.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.